{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:27:30Z","timestamp":1767961650857,"version":"3.49.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ijantimicag.2006.08.046","type":"journal-article","created":{"date-parts":[[2006,12,19]],"date-time":"2006-12-19T09:32:17Z","timestamp":1166520737000},"page":"224-226","source":"Crossref","is-referenced-by-count":12,"title":["Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones"],"prefix":"10.1016","volume":"29","author":[{"given":"Asunci\u00f3n","family":"Fenoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Jos\u00e9","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Coronel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Casal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.08.046_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.49.5.1965-1972.2005","article-title":"Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain","volume":"49","author":"P\u00e9rez-Trallero","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.046_bib2","unstructured":"Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th edn. CLSI document M7-A7. Clinical Laboratory Standards Institute, Wayne, Pa, 2006."},{"key":"10.1016\/j.ijantimicag.2006.08.046_bib3","first-page":"10","article-title":"Situaci\u00f3n de la cefalosporina oral de tercera generaci\u00f3n cefditoren pivoxil en el tratamiento de la infecci\u00f3n comunitaria del adulto","volume":"18","author":"Gimenez","year":"2005","journal-title":"Rev Esp Quimioterap"},{"key":"10.1016\/j.ijantimicag.2006.08.046_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0732-8893(01)00304-2","article-title":"In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren","volume":"42","author":"Karlowsky","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.046_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0732-8893(00)00136-X","article-title":"Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species","volume":"37","author":"Johnson","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.046_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0732-8893(98)00044-3","article-title":"In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae","volume":"31","author":"Jones","year":"1998","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906004171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906004171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T13:59:49Z","timestamp":1547128789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906004171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0924857906004171"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.08.046","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}